Aluminum Hydroxide Adjuvanted Multi-epitope SARS-CoV-2 Vaccine

Preferred Label : Aluminum Hydroxide Adjuvanted Multi-epitope SARS-CoV-2 Vaccine;

NCIt definition : A vaccine composed of chemically synthesized peptides of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) epitopes, conjugated to a recombinant carrier protein, and adsorbed on aluminum hydroxide, with potential immunomodulating and anti-COVID-19 activities. Upon administration of aluminum hydroxide adjuvanted multi-epitope SARS-CoV-2 vaccine, the SARS-CoV-2 peptides activate the immune system to produce antibodies and T-cell responses against these SARS-CoV-2 peptides. This kills SARS-CoV-2 and prevents SARS-CoV-2 infection. The aluminum hydroxide adjuvant improves antigen processing by the immune system.;

Drug name : EpiVacCorona;

NCI Metathesaurus CUI : CL1661226;

Details

Origin ID

C178152;

UMLS CUI

C5554864;

Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
chemical_or_drug_has_mechanism_of_action
- Antigen Sensitization [NCIt concept]
concept_is_in_subset
- NCIt COVID-19 Agent Terminology [NCIt concept]
- NCIt COVID-19 Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients